Journal of Clinical Endocrinology & Metabolism, Vol 68, 232-234, Copyright © 1989 by Endocrine Society

ARTICLES

Functional hypersomatotropism in small for gestational age (SGA) newborn infants

M Deiber, P Chatelain, D Naville, G Putet and B Salle
Department of Neonatology, Hopital Edouard Herriot, Lyon, France.

Basal plasma GH levels and the GH responses to an injection of 1 microgram/kg 1-44(NH2) GHRH were determined on day 3 postnatally in 5 small gestational age (SGA) twin newborns and their appropriate gestational age (AGA) co-twins, and in 10 SGA singleton newborns and 6 AGA singleton newborns. The mean basal plasma GH level was higher in the SGA than in the AGA infants but the difference was significant only for singleton newborns (p less than 0.01). The mean peak plasma GH level was markedly increased in SGA compared to AGA infants (p less than 0.05 for twins, p less than 0.01 for singletons). Twelve SGA infants re-tested at 1 month had lower basal and peak plasma GH levels (p less than 0.001 and p less than 0.01). In 21 SGA and 17 AGA infants, serum IGF-I, measured by RIA between 12 and 96 hours after birth, was significantly higher in SGA than in AGA (p less than 0.001). These results suggest that, whatever the mechanism, functional hypersomatotropism is present at day 3 in SGA infants. This hypersomatotropism may participate in the early catch-up growth process.

This article has been cited by other articles:

				P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter Small for Gestational Age: Short Stature and Beyond Endocr. Rev., April 1, 2007; 28(2): 219 - 251. [Abstract] [Full Text] [PDF]

				M. J. De Blasio, K. L. Gatford, I. C. McMillen, J. S. Robinson, and J. A. Owens Placental Restriction of Fetal Growth Increases Insulin Action, Growth, and Adiposity in the Young Lamb Endocrinology, March 1, 2007; 148(3): 1350 - 1358. [Abstract] [Full Text] [PDF]

				M. J. De Blasio, K. L. Gatford, J. S. Robinson, and J. A. Owens Placental restriction of fetal growth reduces size at birth and alters postnatal growth, feeding activity, and adiposity in the young lamb Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R875 - R886. [Abstract] [Full Text] [PDF]

				L B Johnston and M O Savage Should recombinant human growth hormone therapy be used in short small for gestational age children? Arch. Dis. Child., August 1, 2004; 89(8): 740 - 744. [Abstract] [Full Text] [PDF]

				A. Singhal, T. J. Cole, M. Fewtrell, J. Deanfield, and A. Lucas Is Slower Early Growth Beneficial for Long-Term Cardiovascular Health? Circulation, March 9, 2004; 109(9): 1108 - 1113. [Abstract] [Full Text] [PDF]

				N.K. Arden, P. Major, J.R. Poole, R.W. Keen, S. Vaja, R. Swaminathan, C. Cooper, and T.D. Spector Size at birth, adult intestinal calcium absorption and 1,25(OH)2 vitamin D QJM, January 1, 2002; 95(1): 15 - 21. [Abstract] [Full Text] [PDF]

				C. D Byrne Programming other hormones that affect insulin: Type 2 diabetes Br. Med. Bull., November 1, 2001; 60(1): 153 - 171. [Abstract] [Full Text] [PDF]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				A. L. Ogilvy-Stuart, S. J. Hands, C. J. Adcock, J. M. P. Holly, D. R. Matthews, V. Mohamed-Ali, J. S. Yudkin, A. R. Wilkinson, and D. B. Dunger Insulin, Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1, Growth Hormone, and Feeding in the Newborn J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3550 - 3557. [Abstract] [Full Text]

				F. d. Zegher, I. Francois, m. van helvoirt, and g. van den berghe Small as Fetus and Short as Child: From Endogenous to Exogenous Growth Hormone J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2021 - 2026. [Full Text] [PDF]